HomeCYTO • CVE
add
Cytophage Technologies Ltd
Previous close
$0.24
Day range
$0.21 - $0.24
Year range
$0.13 - $0.58
Market cap
11.04M CAD
Avg Volume
25.83K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.19M | -17.08% |
Net income | -1.24M | 3.93% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -756.17K | 39.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.52M | 4,700.06% |
Total assets | 4.94M | -9.28% |
Total liabilities | 2.01M | -60.42% |
Total equity | 2.93M | — |
Shares outstanding | 53.94M | — |
Price to book | 4.80 | — |
Return on assets | -53.83% | — |
Return on capital | -58.27% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.24M | 3.93% |
Cash from operations | -757.03K | -27.27% |
Cash from investing | -325.02K | 86.97% |
Cash from financing | 252.66K | -90.46% |
Net change in cash | -829.39K | -87.95% |
Free cash flow | -395.67K | — |
About
Headquarters
Website
